Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference
30 Agosto 2022 - 8:05AM
via NewMediaWire – Neovasc, Inc. (Neovasc or the Company) ( NASDAQ
, TSX : NVCN) today announced that its management team will be
participating in the H.C. Wainwright 24th Annual Global Investment
Conference to be held September 12-14, 2022, in New York City.
Neovasc’s President and Chief Executive Officer, Fred Colen, will
be presenting at 1:30 pm ET on Tuesday, September 13, 2022.
A live webcast of the presentation can be accessed using the
link here. Additionally, a recording of the presentation will be
available in the Investors section of the Neovasc website at
Presentations & Events, and will be archived for 90 days.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops,
manufactures, and markets products for the rapidly growing
cardiovascular marketplace. Its products include Reducer, for the
treatment of refractory angina, which is under clinical
investigation in the United States and has been commercially
available in Europe since 2015, and Tiara™ for the transcatheter
treatment of mitral valve disease, which is currently under
clinical investigation in the United States, Canada, Israel and
Europe. For more information, visit: www.neovasc.com.
Forward-Looking Statement Disclaimer
Certain statements in this news release contain forward-looking
statements within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995 and applicable Canadian securities
laws that may not be based on historical fact. When used herein,
the words expect, anticipate, estimate, may, will, should, intend,
believe, and similar expressions, are intended to identify
forward-looking statements. Forward-looking statements may involve,
but are not limited to, the Company’s participation at the 2022
Sidoti & Co. Summer Small Cap Virtual Investor Conference and
the timing thereof and the growing cardiovascular marketplace.
Forward-looking statements are based on estimates and
assumptions made by the Company in light of its experience and its
perception of historical trends, current conditions and expected
future developments, as well as other factors that the Company
believes are appropriate in the circumstances. Many factors could
cause the Company’s actual results, performance or achievements to
differ materially from those expressed or implied by the
forward-looking statements, including those described in the Risk
Factors section of the Company’s Annual Report on Form 20-F and in
the Management’s Discussion and Analysis for the three and six
months ended June 30, 2022 (copies of which may be obtained at
www.sedar.com or www.sec.gov ). These factors should be considered
carefully, and readers should not place undue reliance on the
Company’s forward-looking statements. The Company has no intention
and undertakes no obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise.
Contacts
InvestorsMike CavanaughICR WestwickePhone:
+1.617.877.9641Mike.Cavanaugh@westwicke.com
MediaSean LeousICR WestwickePhone:
+1.646.866.4012Sean.Leous@westwicke.com
Neovasc (NASDAQ:NVCN)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Neovasc (NASDAQ:NVCN)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024